ECRI and the Institute for Safe Medication Practices Launch New Patient Safety Organization

Together, ECRI and ISMP PSO create one of the largest patient safety entities in the world with unparalleled and trusted expertise to keep patients safer

Due to ISMP Advocacy, VinCRIStine Labeling and Packaging Changed to Prevent Wrong Route Administration

ISMP commends the U.S. Food and Drug Administration for requesting that Pfizer revise its current prescribing information and product packaging for vinCRIStine to eliminate syringe administration.

ISMP Warns about Medication Safety Issues with Drug Shortage Replacement Products

Practitioners should be prepared to take extra precautions with vials of neuromuscular blocking agents without the usual “Warning: Paralyzing Agent” statement required on vial caps and a propofol p...

ISMP Alerts Healthcare Practitioners about Medication Errors and Hazards Related to COVID-19

ISMP special edition of the ISMP Medication Safety Alert!® acute care newsletter provides details on reports of emerging medication-related events and risks due to the COVID-19 pandemic. The specia...

Healthcare Workers Need Support from Leaders During Emotional Turmoil of Pandemic

ISMP special edition of the ISMP Medication Safety Alert!® acute care newsletter highlights the need to address the stress, anxiety, exhaustion, and depression healthcare workers are facing due to ...

Near Miss Dosing Error for Unapproved Drug Used to Hasten COVID Recovery

ISMP special edition of the acute care newsletter this week provides information on an error-prone dose expression on the label of an unapproved drug, ascorbic acid, that is being used to hasten re...